PA 08-12—sSB 579

Public Health Committee

AN ACT CONCERNING METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS

SUMMARY: By January 1, 2009, this act requires each licensed hospital to develop a plan to reduce the incidence of methicillin-resistant staphylococcus aureus (MRSA) infection at the hospital. The MRSA plan must at least include the hospital's strategies for reducing such infections. Each hospital must provide its plan, which is a public record, to the Department of Public Health.

MRSA means the strain of staphylococcus aureus bacteria that is resistant to oxacillin or methicillin and detected and defined according to the Clinical and Laboratory Standards Institute's (CLSI) Performance Standards for Antimicrobial Susceptibility Testing.

The act applies to licensed hospitals which, by law, are establishments for the lodging, care, and treatment of people suffering from disease or other abnormal physical or mental conditions and includes inpatient psychiatric services in general hospitals.

EFFECTIVE DATE: July 1, 2008

BACKGROUND

CLSI

CLSI is a global, nonprofit standards-developing organization that promotes the development and use of voluntary consensus standards and guidelines within the health care community. It includes over 2,000 member organizations concerned with improving health care quality.

In 1977, CLSI was first accredited by the American National Standards Institute as a voluntary consensus standards organization. At about the same time, CLSI became the home of the National Reference System for the Clinical Laboratory—a collection of broadly understood reference systems intended to improve the comparability of test results consistent with the needs of medical practice.

OLR Tracking: JK: KM: CR: dw